Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation.
Cancer Med. 2023 Feb;12(4):4270-4281. doi: 10.1002/cam4.5297. Epub 2022 Sep 23.
Cancer Med. 2023.
PMID: 36151773
Free PMC article.
Clinical Trial.
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML.
Niyongere S, Lucas N, Zhou JM, Sansil S, Pomicter AD, Balasis ME, Robinson J, Kroeger J, Zhang Q, Zhao YL, Ball M, Komrokji R, List A, Deininger MW, Fridley BL, Santini V, Solary E, Padron E.
Niyongere S, et al. Among authors: sansil s.
Leukemia. 2019 Jan;33(1):205-216. doi: 10.1038/s41375-018-0203-0. Epub 2018 Jul 19.
Leukemia. 2019.
PMID: 30026572
Free PMC article.
Item in Clipboard
Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase.
Vena F, Bayle S, Nieto A, Quereda V, Aceti M, Frydman SM, Sansil SS, Grant W, Monastyrskyi A, McDonald P, Roush WR, Teng M, Duckett D.
Vena F, et al. Among authors: sansil ss.
Mol Cancer Ther. 2020 Aug;19(8):1623-1635. doi: 10.1158/1535-7163.MCT-19-0997. Epub 2020 May 19.
Mol Cancer Ther. 2020.
PMID: 32430484
Free PMC article.
Item in Clipboard
Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic.
Apostolatos AH, Apostolatos CA, Ratnayake WS, Neuger A, Sansil S, Bourgeois M, Acevedo-Duncan M.
Apostolatos AH, et al. Among authors: sansil s.
Anticancer Drugs. 2019 Jan;30(1):65-71. doi: 10.1097/CAD.0000000000000694.
Anticancer Drugs. 2019.
PMID: 30204596
Free PMC article.
Item in Clipboard
Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth.
Tauro M, Shay G, Sansil SS, Laghezza A, Tortorella P, Neuger AM, Soliman H, Lynch CC.
Tauro M, et al. Among authors: sansil ss.
Mol Cancer Ther. 2017 Mar;16(3):494-505. doi: 10.1158/1535-7163.MCT-16-0315-T. Epub 2017 Jan 9.
Mol Cancer Ther. 2017.
PMID: 28069877
Free PMC article.
Item in Clipboard
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties.
Morozova A, Chan SC, Bayle S, Sun L, Grassie D, Iermolaieva A, Kalaga MN, Frydman S, Sansil S, Schönbrunn E, Duckett D, Monastyrskyi A.
Morozova A, et al. Among authors: sansil s.
Eur J Med Chem. 2024 Feb 15;266:116101. doi: 10.1016/j.ejmech.2023.116101. Epub 2023 Dec 29.
Eur J Med Chem. 2024.
PMID: 38232465
Item in Clipboard
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
Saltos AN, Creelan BC, Tanvetyanon T, Chiappori AA, Antonia SJ, Shafique MR, Ugrenovic-Petrovic M, Sansil S, Neuger A, Ozakinci H, Boyle TA, Kim J, Haura EB, Gray JE.
Saltos AN, et al. Among authors: sansil s.
Lung Cancer. 2023 Sep;183:107313. doi: 10.1016/j.lungcan.2023.107313. Epub 2023 Jul 22.
Lung Cancer. 2023.
PMID: 37499521
Clinical Trial.
Item in Clipboard
Cite
Cite